RHYTHM PHARMACEUTICALS, INC.

RYTM

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091684
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Mathers Edward T (Director)

Summary

Type

Neutral

Net shares

+4,198

% of shares

32.87%

Amount (USD)

$0

Insider confidence score

90.0 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Minimal buy amount (<$10K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Buy

Date

2026-03-02

Code

J

Net shares

+4,198.0

Acquired/Disposed

Acquired

Shares Owned Before

5,771.0

Shares Owned After

9,969.0

Filing's footnotes

1. NEA Partners 13, L.P. (&quot;NEA Partners 13&quot;) made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 2, 2026. The Edward Timothy Mathers Revocable Trust (the &quot;Mathers Trust&quot;) received 4,198 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 2, 2026.

2. The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.